Literature DB >> 23404207

The saponin monomer of dwarf lilyturf tuber, DT-13, inhibits angiogenesis under hypoxia and normoxia via multi-targeting activity.

Renping Zhao1, Li Sun, Sensen Lin, Xianshu Bai, Boyang Yu, Shengtao Yuan, Luyong Zhang.   

Abstract

The saponin monomer of dwarf lilyturf tuber, DT-13, exhibits anticancer activity by reducing human breast cancer cell adhesion and migration under hypoxia. To further investigate the anticancer activity of DT-13, we investigated whether DT-13 exhibits anti-angiogenic activity. DT-13 showed no effect on human umbilical vein endothelial cell proliferation but inhibited tube formation and migration under normoxia and hypoxia. Moreover, DT-13 significantly reduced density of vessels in vivo observed from a chicken chorioallantoic membrane model. Western blotting results showed that DT-13 suppressed the increased level of hypoxia-inducible factor 1α, p-extracellular signal-regulated kinase 1/2 and p-Akt induced by hypoxia. Enzyme-linked immunosorbent assay revealed that vascular endothelial growth factor excretion was suppressed by DT-13. DT-13 inhibited migration and tube formation induced by vascular endothelial growth factor under normoxia and hypoxia. In addition, DT-13 reduced the level of p-vascular endothelial growth factor receptor 2 and p-Akt induced by vascular endothelial growth factor. Our data suggest that DT-13 inhibits angiogenesis under normoxia and hypoxia and also inhibits angiogenesis induced by vascular endothelial growth factor via targeting at multi elements.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404207     DOI: 10.3892/or.2013.2272

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

Review 1.  Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.

Authors:  Devarajan Nalini; Jayaraman Selvaraj; Ganesan Senthil Kumar
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-13       Impact factor: 4.553

2.  Saponin monomer 13 of dwarf lilyturf tuber (DT-13) protects serum withdrawal-induced apoptosis through PI3K/Akt in HUVEC.

Authors:  Cong Qiu; Levente Jozsef; Boyang Yu; Jun Yu
Journal:  Biochem Biophys Res Commun       Date:  2013-11-19       Impact factor: 3.575

3.  Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue.

Authors:  Lai Wang; Zu-Guo Zheng; Lingchang Meng; Lijun Zhu; Ping Li; Jun Chen; Hua Yang
Journal:  Cell Biol Toxicol       Date:  2020-10-09       Impact factor: 6.691

4.  The saponin DT-13 attenuates tumor necrosis factor-α-induced vascular inflammation associated with Src/NF-кB/MAPK pathway modulation.

Authors:  Yuanyuan Zhang; Minhui Sun; Yuwei Han; Kefeng Zhai; Youmei Tang; Xiaoying Qin; Zhengyu Cao; Boyang Yu; Junping Kou
Journal:  Int J Biol Sci       Date:  2015-06-11       Impact factor: 6.580

5.  Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo.

Authors:  Xiao-Wen Yu; Sensen Lin; Hong-Zhi Du; Ren-Ping Zhao; Shu-Yun Feng; Bo-Yang Yu; Lu-Yong Zhang; Rui-Ming Li; Chang-Min Qian; Xue-Jun Luo; Sheng-Tao Yuan; Li Sun
Journal:  Oncotarget       Date:  2016-05-31

6.  DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.

Authors:  Hongyang Li; Li Sun; Hang Li; Xiaodan Lv; Herve Semukunzi; Ruiming Li; Jun Yu; Shengtao Yuan; Sensen Lin
Journal:  Cell Death Dis       Date:  2017-05-25       Impact factor: 8.469

7.  DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway.

Authors:  Zhengming Wang; Yingying Wang; Shan Zhu; Yao Liu; Xin Peng; Shaolu Zhang; Zhe Zhang; Yuling Qiu; Meihua Jin; Ran Wang; Yuxu Zhong; Dexin Kong
Journal:  Front Pharmacol       Date:  2018-12-07       Impact factor: 5.810

8.  Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis.

Authors:  Xiao-Wen Yu; Dandan Wei; Ying-Sheng Gao; Hong-Zhi Du; Bo-Yang Yu; Rui-Ming Li; Chang-Min Qian; Xue-Jun Luo; Sheng-Tao Yuan; Jun-Song Wang; Li Sun
Journal:  J Cell Mol Med       Date:  2019-08-09       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.